We are live on ! Find out more
CPX

Canaan Partners XI Portfolio holdings

AUM $127M
1-Year Est. Return 217.49%
This Fund
S&P 500
This Quarter Est. Return
-8.48%
1 Year Est. Return
+217.49%
3 Year Est. Return
+1,311.52%
5 Year Est. Return
10 Year Est. Return
AUM
$103M
AUM Growth
-$68.9M
Cap. Flow
-$1.23M
Cap. Flow %
-1.2%
Top 10 Hldgs %
100%
Holding
4
New
Increased
Reduced
1
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
UPBD icon
Upbound Group
UPBD
+$974K
2
RLYB icon
Rallybio
RLYB
+$258K

Sector Composition

Rank Sector Weight
1 Technology 50.71%
2 Healthcare 49.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AEVA
1
Aeva Technologies
AEVA
$1.02B
$52.2M 50.71%
3,597,039
TYRA icon
2
Tyra Biosciences
TYRA
$1.82B
$50.5M 49.07%
3,608,109
RLYB icon
3
Rallybio
RLYB
$86.6M
$225K 0.22%
56,250
-61,373
-52% -$258K
UPBD icon
4
Upbound Group
UPBD
$1.19B
-38,824
Closed -$974K

Similar funds

Canaan Partners XI's Q3 2025 Portfolio in Review

As of Q3 2025, Canaan Partners XI held 4 positions worth $103M, down 40% from $172M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Canaan Partners XI's Q3 2025 filing shows 1 reduced and 1 closed positions. The largest sale was Upbound Group, an estimated $974K.

By sector, the portfolio is most concentrated in Technology at 51% of assets, down from 80% a quarter earlier, followed by Healthcare.

  • Canaan Partners XI's biggest Q3 2025 reduction was Rallybio, cutting an estimated $258K.
  • Canaan Partners XI fully exited Upbound Group in Q3 2025, selling an estimated $974K.
  • Canaan Partners XI's ten largest holdings make up 100% of its $103M portfolio in Q3 2025.
  • Canaan Partners XI opened 0 new positions and closed 1 in Q3 2025.
  • Canaan Partners XI's portfolio value fell 40% quarter-over-quarter to $103M.

Based on Canaan Partners XI's 13F filing for Q3 2025, filed 23 Oct 2025.